Nov 24, 2021 (AmericaNewsHour) -- Research Nester published a report titled "Migraine treatment drugs market- Global Demand Analysis and Opportunity Outlook 2020-2028" which delivers detailed overview of the migraine treatment drugs market in terms of market segmentation by type, by treatment type, by route of administration, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter's five force model.
The market for migraine treatment drugs is anticipated to record a CAGR of around 12% over the forecast period 2020-2028. The major key factors accelerating the growth of the market include increasing prevalence of migraine and improved healthcare infrastructure. Further, rising demand for hormonal medications, rising cigarette consumption, novel product innovations and stressed lifestyle are adding up to the reasons fostering the growth of the market. The treatment type is segmented into abortive treatment and preventive treatment, out of which, the largest share in the market will be shown by abortive segment on the account of quick working of the medication towards migraine once it starts, which relieves the pain and symptoms of a migraine attack.
"The Final Report will cover the impact analysis of COVID-19 on this industry."
Download/Request Sample Copy of Strategic Report: https://www.researchnester.com/sample-request-2752
Based on the regional analysis, the market for migraine treatment drugs is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The Migraine treatment drugs market in North America is estimated to dominate the market on the account of rising population leading to the prevalence of migraine and launch of CGRP (Calcitonin gene-related peptide) based therapies. The Asia Pacific region is anticipated to have highest growth rate on the back of growing disease awareness, high penetration from drug manufacturers and low cost production of migraine treatment drugs in major emerging economies. These factors are anticipated to drive the market growth over the forecast period.
Rising Female Population and Awareness Regarding Migraine
Migraine is a female disorder and prevalence of migraine in women is three times more than men. The reproductive cycle of women is regulated through the release of estrogen and variation in the levels of estrogen at the time of menstrual cycle, menopause and pregnancy results in migraine in women. Further, national and international headache societies are preparing some educational programs regarding awareness about migraine. In addition, social factors such as break-up of families and increased financial burdens causing stress to the people are growing demand for migraine treatment drugs. These factors are anticipated to account for the growth in the market over the forecast period.
However, multiple side effects related to the medications of migraine are expected to operate as a key restraint towards the growth of migraine treatment drugs market over the forecast period.
Download Sample of This Strategic Report: https://www.researchnester.com/sample-request-2752
This report also provides the existing competitive scenario of some of the key players of the migraine treatment drugs market which includes company profiling of Pfizer Inc. /zigman2/quotes/202877789/composite PFE -2.33% , Eli Lilly and Company /zigman2/quotes/200106384/composite LLY -0.03% , Eisai Co. Ltd. (tyo:4523), Amneal Pharmaceuticals Inc. /zigman2/quotes/209301288/composite AMRX +1.36% , Abbott Laboratories /zigman2/quotes/203724446/composite ABT +0.90% , Novartis International AG (swx:NOVN), Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.52% , Teva Pharmaceutical Industries /zigman2/quotes/205657894/composite TEVA -1.50% and Endo International Plc. /zigman2/quotes/207745412/composite ENDP -3.31% . The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the migraine treatment drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Browse Complete Summary of this report @ https://www.researchnester.com/reports/migraine-treatment-drugs-market/2752
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.
Contact for more Info:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.